Author Correction: Propylene glycol inactivates respiratory viruses and prevents airborne transmission
Christine T Styles, Jie Zhou, Katie E Flight, Jonathan C Brown, Charlotte Lewis, Xinyu Wang, Michael Vanden Oever, Thomas P Peacock, Ziyin Wang, Rosie Millns, John S O’Neill, Alexander Borodavka, Joe Grove, Wendy S Barclay, John S Tregoning, Rachel S Edgar
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInhalation and Respiratory Drug Delivery · Respiratory viral infections research
Correction to: EMBO Molecular Medicine (2023) 15:e17932. 10.15252/emmm.202317932 | Published online 16 November 2023
The Abstract is updated.
A citation is added.
In the Abstract, the sentence—
“We present PG vapour as a first-in-class non-toxic airborne virucide that can prevent transmission of existing and emergent viral pathogens, with clear and immediate implications for public health”.
Is updated to: Changes are in bold.
“We present PG vapour as a novel non-toxic airborne virucide that can prevent transmission of existing and emergent viral pathogens, with clear and immediate implications for public health”.
The citation is added:
Desai G, Ramachandran G, Goldman E, Esposito W, Galione A, Lal A, Choueiri TK, Fay A, Jordan W, Schaffner DW, Caravanos J, Grignard E, Mainelis G (2023). Efficacy of Grignard Pure to inactivate airborne phage MS2, a common SARS-CoV-2 surrogate. Environ Sci Technol 57(10):4231–4240
Author Statement:
The authors note that they missed a citation to Desai et al., 2023, which reported the inactivation of bacteriophage MS2 by another agent, triethylene glycol. Although Desai et al did not test for virucidal activity against clinically important human pathogens, in vivo efficacy or potential toxicity, for the avoidance of doubt the statement “first-in-class non-toxic airborne virucide” in the Abstract was thus corrected to “novel non-toxic airborne virucide”.